Biovet on June 20 said it will invest Rs 200 crore to expand existing facilities at Malur in Karnataka to make vaccines for Foot & Mouth Disease (FMD) and Brucellosis disease.
The animal vaccine company will manufacture 200 million doses of the FMD vaccine and 100 million doses of the Brucella vaccine, pushing the company's overall capacity from 200 million to 500 million doses.
The process once completed would make Biovet one of the world's largest FMD vaccine makers. It would compete against the Indian Immunologicals (IIL), a National Dairy Development Board subsidiary.
With a capacity to produce 360 million doses, IIL is the world’s top FMD vaccine producer and supplies around 80 percent of the doses for the control programme in India.